Glanbia plc (GLAPY)
OTCMKTS · Delayed Price · Currency is USD
71.00
+7.65 (12.08%)
At close: Jun 3, 2025
Revance Therapeutics Market Cap
Glanbia has a market cap or net worth of $3.61 billion as of August 8, 2025. Its market cap has decreased by -30.21% in one year.
Market Cap
3.61B
Enterprise Value
4.23B
Revenue
3.84B
Ranking
n/a
PE Ratio
21.94
Stock Price
$71.00
Market Cap Chart
Since March 31, 1997, Glanbia's market cap has increased from 1.13B to 3.61B, an increase of 219.59%. That is a compound annual growth rate of 4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.61B | 2.07% |
| Dec 31, 2024 | 3.54B | -18.43% |
| Dec 29, 2023 | 4.34B | 25.32% |
| Dec 30, 2022 | 3.46B | -13.57% |
| Dec 31, 2021 | 4.01B | 7.50% |
| Dec 31, 2020 | 3.73B | 9.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cordyceps Sunshine Biotech Holdings | 1.02B |
| Cuisine Solutions | 425.59M |
| Armanino Foods of Distinction | 258.17M |
| South Dakota Soybean Processors, LLC | 203.76M |
| Microalliance Group | 182.79M |
| ESG Inc. | 144.26M |
| Pyxus International | 118.12M |
| Crimson Wine Group | 114.25M |